| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Hepion Pharmaceuticals, Inc.
13D/A
HEPA · 426897401
|
26.2% |
8/20/2026
Event 8/3/2026
|
||||
| Gravitas Capital LP | 21.4% | |||||
| Invictus Capital Advisors Pension Plan | 5.7% | |||||
| Vincent LoPriore | 26.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.